Showing results (41-50 of 175) with videos related to

Sort By:
Pageof 18
American Journal of Clinical Oncology|October 1, 1995
Aminothiadiazole in the treatment of advanced leiomyosarcoma of the uterine corpus. A Gynecologic Oncology Group studyR Asbury, J A Blessing, D M Smith, et al.
American Journal of Clinical Oncology|October 1, 1989
Aminothiadiazole (NSC 4728) in patients with advanced nonsquamous carcinoma of the cervix. A phase II study of the Gynecologic Oncology GroupR F Asbury, J A Blessing, P J DiSaia, et al.
American Journal of Clinical Oncology|December 1, 1992
5-fluorouracil and low-dose leucovorin in the treatment of recurrent epithelial ovarian carcinoma. A phase II trial of the Gynecologic Oncology GroupK Y Look, J A Blessing, H B Muss, et al.
Gynecologic Oncology|September 19, 1998
Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group studyP G Rose, J A Blessing, L Van Le, et al.
Investigational New Drugs|November 1, 1990
Phase II trial of vinblastine in advanced ovarian carcinoma. A Gynecologic Oncology Group studyG P Sutton, J A Blessing, M D Adelson, et al.
Cancer Chemotherapy and Pharmacology|June 10, 1998
Tomudex (ZD1694, NSC 639186) in platinum-pretreated recurrent epithelial ovarian cancer: a phase II study by the Gynecologic Oncology GroupF M Muggia, J A Blessing, H D Homesley, et al.
American Journal of Obstetrics and Gynecology|February 1, 1992
Phase II trial of ifosfamide and mesna in leiomyosarcoma of the uterus: a Gynecologic Oncology Group studyG P Sutton, J A Blessing, R J Barrett, et al.
American Journal of Clinical Oncology|October 1, 1995
A phase II study of fazarabine (NSC 281272) in patients with advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group studyA Manetta, J A Blessing, W J Mann, et al.
Investigational New Drugs|February 1, 1991
A phase II trial of gallium nitrate (NSC #15200) in advanced or recurrent squamous cell carcinoma of the cervix. A Gynecologic Oncology Group studyJ H Malfetano, J A Blessing, H D Homesley, et al.
American Journal of Clinical Oncology|December 1, 1988
A phase II clinical trial of diaziquone in the treatment of patients with recurrent endometrial carcinoma. A Gynecologic Oncology Group studyR E Slayton, J A Blessing, P J DiSaia, et al.
Pageof 18